Thyroid cancer
Pathology
Approximate Frequency of Malignant Thyroid Tumors.
Papillary carcinoma (including mixed papillary and follicular)                                              80
                                                                                                            %
Follicular carcinoma (including Hürthle cell carcinoma)                                                     10
                                                                                                            %
Medullary carcinoma                                                                                         5
                                                                                                            %
Undifferentiated carcinomas                                                                                 3
                                                                                                            %
Miscellaneous (including lymphoma, fibrosarcoma, squamous cell carcinoma, malignant hemangioendothelioma,   1
teratomas, and metastatic carcinomas)                                                                       %
             Papillary Carcinoma
• Papillary carcinoma of the thyroid gland usually presents
  as a nodule that is firm, solitary, "cold" on isotope scan,
  solid on thyroid ultrasound, and clearly different from
  the rest of the gland.
• In multinodular goiter, the cancer is usually a "dominant
  nodule"—larger, firmer, and (again) clearly different
  from the rest of the gland.
• About 10% of papillary carcinomas, especially in
  children, present with enlarged cervical nodes, but
  careful examination often reveals a nodule in the
  thyroid.
            Papillary Carcinoma
• Microscopically, the tumor consists of single layers
  of thyroid cells arranged in vascular stalks, with
  papillary projections extending into microscopic
  cyst-like spaces. The nuclei of the cells are large
  and pale and frequently contain clear, glassy
  intranuclear inclusion bodies. About 40% of
  papillary carcinomas form laminated calcified
  spheres—often at the tip of a papillary projection
  —called "psammoma bodies," which are usually
  diagnostic of papillary carcinoma.
          Papillary Carcinoma
• These cancers usually extend by intraglandular
  metastasis and by local lymph node invasion.
• They grow very slowly and remain confined to
  the thyroid gland and local lymph nodes for
  many years. In older patients, they may
  become more aggressive and invade locally
  into muscles and trachea.
                Papillary Carcinoma
• In later stages, they can spread to the lung. Death is usually due to
  local disease, with invasion of deep tissues in the neck; less commonly,
  death may be due to extensive pulmonary metastases.
• In some older patients, a long-standing, slowly growing papillary
  carcinoma begins to grow rapidly and converts to undifferentiated or
  anaplastic carcinoma. This "late anaplastic shift" is another cause of
  death from papillary carcinoma.
• Many papillary carcinomas secrete thyroglobulin, which can be used as
  a marker for recurrence or metastasis of the cancer.
• Most papillary cancers concentrate radioiodine, albeit much less
  efficiently than normal thyroid tissue: this is why they appear as "cold"
  nodules on radionuclide scan. But, for this same reason, radioiodine
  can be used as the primary therapy for recurrent or metastatic disease.
           Follicular Carcinoma
• Follicular carcinoma is characterized histologically
  by the presence of small follicles, although colloid
  formation is poor
• The tumor is somewhat more aggressive than
  papillary carcinoma and can spread either by local
  invasion of lymph nodes or by blood vessel invasion
  with distant metastases to bone or lung.
• Microscopically, the cells are cuboidal, with large
  nuclei, arranged around follicles that frequently
  contain dense colloid.
           Follicular Carcinoma
• These tumors often retain the ability to
  concentrate radioactive iodine, to form
  thyroglobulin, and, rarely, to synthesize T3 and T4.
  Thus, the rare "functioning thyroid cancer" is
  almost always a follicular carcinoma. This
  characteristic makes these tumors more likely to
  respond to radioactive iodine therapy. Death is
  due to local extension or to distant bloodstream
  metastasis with extensive involvement of bone,
  lungs, and viscera.
         Medullary Carcinoma
• Medullary cancer is a disease of the C cells
  (parafollicular cells) derived from the
  ultimobranchial body and capable of secreting
  calcitonin, carcinoembryonic antigen (CEA),
  histaminase, prostaglandins, serotonin, and
  other peptides.
          Medullary Carcinoma
• Medullary carcinoma is somewhat more aggressive
  than papillary or follicular carcinoma but not as
  aggressive as undifferentiated thyroid cancer.
• It extends locally into lymph nodes and into
  surrounding muscle and trachea. It may invade
  lymphatics and blood vessels and metastasize to
  lungs and viscera.
• Calcitonin and CEA secreted by the tumor are
  clinically useful markers for diagnosis and follow-
  up.
 Undifferentiated (Anaplastic) Carcinoma
• Undifferentiated thyroid gland tumors include
  small cell, giant cell, and spindle cell carcinomas.
  They usually occur in older patients with a long
  history of goiter in whom the gland suddenly—
  over weeks or months—begins to enlarge and
  produce pressure symptoms, dysphagia, or vocal
  cord paralysis. Death from massive local
  extension usually occurs within 6–36 months.
  These tumors are very resistant to therapy.